HOWL Werewolf Therapeutics, Inc.

Fundamentals / CIK 0001785530 / USD

Werewolf Therapeutics, Inc. reported $42.75M in total assets and a net loss of $28.12M through December 31, 2025 from SEC EDGAR filings.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open HOWL in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

6 fiscal years (2020 to 2025), reported in USD.

$0$0$0-$65.93MFY 2020 Net Income: -$15.04M2020FY 2021 Net Income: -$49.98M2021FY 2022 Net Income: -$53.81M2022FY 2023 Net Income: -$37.37M2023FY 2024 Net Income: -$70.52M2024FY 2025 Net Income: -$60.82M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Research & Development $44.83M $56.43M $41.78M $53.76M $35.27M $16.64M
Total Operating Expenses $60.68M $75.48M $60.45M $72.46M $50.09M $22.40M
Operating Income -$60.68M -$73.59M -$40.50M -$56.06M -$50.09M -$22.40M
EBITDA -$59.04M -$71.78M -$38.74M -$54.95M -$49.87M -$22.25M
Interest Income $3.11M $6.67M $7.42M $1.91M -- --
Interest Expense $5.27M $4.66M $3.14M $0 -- --
Income Tax Expense $0 -- -- -- -- --
Net Income -$60.82M -$70.52M -$37.37M -$53.81M -$49.98M -$15.04M
Basic EPS -$1.32 -$1.63 -$1.05 -$1.86 -$10.94 -$28.08
Diluted EPS -$1.33 -$1.63 -$1.05 -$1.86 -$10.94 -$28.08
Basic Shares Outstanding 46.0M 43.3M 35.6M 28.9M 18.5M 1.0M
Diluted Shares Outstanding 46.8M 43.9M 35.6M 28.9M 18.5M 1.0M

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Research & Development $2.17M $6.16M $8.18M $6.93M $11.63M $13.14M $13.12M $15.73M
Total Operating Expenses $10.05M $13.84M $13.27M $9.42M $15.73M $17.54M $17.99M $20.35M
Operating Income -$10.05M $7.16M -$13.27M -$9.42M -$15.73M -$17.54M -$17.99M -$20.35M
EBITDA -$8.79M $9.61M -$12.87M -$9.02M -$15.32M -$17.14M -$17.57M -$19.91M
Interest Income $183K $277K $433K $564K $697K $850K $997K $1.31M
Interest Expense $0 $475K $1.37M $1.37M $1.34M $1.30M $1.26M $1.27M
Net Income -$9.88M $3.67M -$13.53M -$8.38M -$16.37M -$17.98M -$18.09M -$20.40M
Basic EPS -$0.20 $0.08 -$0.28 -- -$0.36 -$0.40 -$0.40 --
Diluted EPS -$0.20 $0.08 -$0.28 -- -$0.36 -$0.40 -$0.40 --
Basic Shares Outstanding 48.6M 48.6M 48.6M -- 45.8M 45.0M 44.8M --
Diluted Shares Outstanding 48.6M 48.6M 49.4M -- 45.8M 45.0M 44.8M --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $57.05M $111.0M $134.3M $129.3M $157.5M $92.57M
Cash & Short-Term Investments $57.05M $111.0M $134.3M $129.3M $157.5M $92.57M
Total Current Assets $58.59M $113.1M $138.4M $140.2M $161.1M $92.91M
Property, Plant & Equipment, Net $4.69M $6.32M $7.96M $8.99M $2.91M $651K
Other Non-Current Assets $5.0K $320K $594K $1.38M $649K $0
Total Non-Current Assets $10.81M $13.86M $36.46M $20.05M $18.18M $3.48M
Total Assets $69.40M $126.9M $174.8M $160.2M $179.2M $96.40M
Accounts Payable $754K $3.04M $1.34M $1.22M $2.04M $1.02M
Deferred Revenue (Current) $0 $0 $907K $6.53M $0 --
Other Current Liabilities -- -- -- $6.53M $0 $0
Total Current Liabilities $36.15M $15.18M $19.38M $23.99M $11.87M $5.28M
Long-Term Debt $32.09M $32.09M $40.00M -- -- --
Deferred Revenue (Non-Current) -- $0 $433K $1.13M $0 --
Other Non-Current Liabilities -- -- $0 $191K $0 $31K
Total Non-Current Liabilities $8.44M $38.36M $44.08M $13.92M $14.59M $1.90M
Total Liabilities $44.59M $53.54M $63.46M $37.91M $26.46M $7.18M
Total Debt (incl. Leases) $41.52M $43.08M $52.60M $14.68M $15.66M $2.54M
Common Stock $5.0K $5.0K $4.0K $3.0K $2.0K $2.0K
Retained Earnings -$475.4M -$414.6M -$344.1M -$306.7M -$252.9M -$51.87M
Total Stockholders' Equity $24.80M $73.39M $111.4M $122.3M $152.8M -$51.86M
Total Equity $24.80M $73.39M $111.4M $122.3M $152.8M -$51.86M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $41.87M $21.99M $46.45M $57.05M $65.71M $77.60M $92.04M $111.0M
Cash & Short-Term Investments $41.87M $21.99M $46.45M $57.05M $65.71M $77.60M $92.04M $111.0M
Total Current Assets $42.75M $22.89M $48.73M $58.59M $68.17M $80.44M $94.46M $113.1M
Property, Plant & Equipment, Net $0 $1.26M $4.29M $4.69M $5.09M $5.49M $5.90M $6.32M
Other Non-Current Assets $0 $0 $0 $5.0K $46K $122K $179K $320K
Total Non-Current Assets $0 $1.26M $9.29M $10.81M $11.45M $12.13M $12.78M $13.86M
Total Assets $42.75M $24.16M $58.02M $69.40M $79.63M $92.57M $107.2M $126.9M
Accounts Payable $2.43M $1.94M $3.57M $754K $1.08M $2.77M $986K $3.04M
Deferred Revenue (Current) $28.85M -- -- $0 -- -- -- $0
Total Current Liabilities $35.99M $7.86M $38.52M $36.15M $17.60M $15.17M $11.67M $15.18M
Long-Term Debt -- -- $32.09M $32.09M $32.09M $32.09M $32.09M $32.09M
Deferred Revenue (Non-Current) -- -- -- -- -- -- -- $0
Total Non-Current Liabilities $0 $0 $7.30M $8.44M $32.41M $35.93M $38.26M $38.36M
Total Liabilities $35.99M $7.86M $45.82M $44.59M $50.01M $51.10M $49.93M $53.54M
Total Debt (incl. Leases) -- -- $40.91M $41.52M $41.73M $42.13M $42.51M $43.08M
Common Stock $5.0K $5.0K $5.0K $5.0K $5.0K $5.0K $5.0K $5.0K
Retained Earnings -$495.1M -$485.3M -$488.9M -$475.4M -$467.0M -$450.7M -$432.7M -$414.6M
Total Stockholders' Equity $6.76M $16.29M $12.20M $24.80M $29.61M $41.46M $57.31M $73.39M
Total Equity $6.76M $16.29M $12.20M $24.80M $29.61M $41.46M $57.31M $73.39M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Net Income -$60.82M -$70.52M -$37.37M -$53.81M -$49.98M -$15.04M
Depreciation & Amortization $1.63M $1.81M $1.76M $1.10M $216K $150K
Stock-Based Compensation $6.25M $8.83M $8.01M $7.40M $4.09M $632K
Change in Payables -- -- -- -$883K $1.01M $388K
Operating Cash Flow -$60.29M -$56.19M -$32.61M -$40.60M -$42.88M -$18.62M
Capital Expenditure $0 -$254K -$769K -$3.61M -$498K -$560K
Free Cash Flow -$60.29M -$56.44M -$33.38M -$44.21M -$43.37M -$19.18M
Investing Cash Flow $0 -$254K -$769K -$3.61M -$498K -$560K
Common Stock Issued $5.94M $23.58M $18.33M $15.74M $0 --
Financing Cash Flow $6.03M $13.08M $58.43M $15.91M $109.4M $93.86M
Net Change in Cash -$54.26M -$43.36M $25.05M -$28.30M $66.05M $74.67M

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income -$9.88M $3.67M -$13.53M -$8.38M -$16.37M -$17.98M -$18.09M -$20.40M
Depreciation & Amortization $1.26M $2.45M $398K $400K $402K $406K $426K $442K
Stock-Based Compensation $344K $419K $929K $1.21M $1.23M $1.79M $2.01M $1.91M
Operating Cash Flow -$8.97M $6.63M -$10.60M -$11.02M -$15.16M -$15.16M -$18.95M -$14.25M
Capital Expenditure -- -- -- $0 $0 $0 $0 -$123K
Free Cash Flow -- -- -- -$11.02M -$15.16M -$15.16M -$18.95M -$14.38M
Investing Cash Flow -- -- -- $0 $0 $0 $0 -$123K
Common Stock Issued -- -- -- $2.32M $3.27M $347K $0 $2.48M
Financing Cash Flow -- -- -- $2.37M $3.27M $388K $0 $2.55M
Net Change in Cash $19.88M -$25.37M -$10.60M -$8.66M -$11.88M -$14.78M -$18.95M -$11.83M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Return on Equity (ROE) -245.2% -96.1% -33.6% -44.0% -32.7% --
Return on Assets (ROA) -87.6% -55.6% -21.4% -33.6% -27.9% -15.6%
Current Ratio 1.62x 7.45x 7.14x 5.84x 13.56x 17.58x
Quick Ratio 1.58x 7.31x 6.93x 5.39x 13.27x 17.52x
Debt to Equity 1.67x 0.59x 0.47x 0.12x 0.10x --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Return on Equity (ROE) -416.0% -212.5% -461.1% -245.2% -246.0% -176.4% -126.4% -96.1%
Return on Assets (ROA) -65.8% -143.3% -97.0% -87.6% -91.5% -79.0% -67.5% -55.6%
Current Ratio 1.19x 2.91x 1.27x 1.62x 3.87x 5.30x 8.09x 7.45x
Quick Ratio 1.16x 2.80x 1.21x 1.58x 3.73x 5.11x 7.89x 7.31x
Debt to Equity -- -- 3.35x 1.67x 1.41x 1.02x 0.74x 0.59x
Source: SEC EDGAR CompanyFacts (CIK 0001785530) · from March 31, 2020 Data through September 30, 2026 · synced Nov 20, 2026, 05:53 UTC · Open in terminal